ArticlePharmaceutical research2006

Development of 5-FU and doxorubicin-loaded cationic liposomes against human pancreatic cancer: Implications for tumor vascular targeting.

Ashish V Kalra et al.PubMed ↗Publisher ↗

No numbers read from the abstract.